0000-0002-9426-1193 About
Dr. Junaid Iqbal is an internal medicine specialist and medical researcher with expertise in endocrinology, metabolism, and cardiometabolic diseases. He is affiliated with the Second Xiangya Hospital of Central South University, China, where his research focuses on obesity, metabolic risk stratification, and prevention of cardiovascular and cerebrovascular diseases.
He is the developer and first author of MetsObesity, a novel classification framework designed to predict long-term cardiometabolic risk using modifiable clinical factors, validated in large population-based cohorts including the UK Biobank. His work emphasizes preventive medicine, metabolic health, and global applicability of risk assessment tools.
Dr. Iqbal has authored and co-authored more than 12 peer-reviewed scientific publications in international journals. His broader research interests include obesity, type 2 diabetes, metabolic syndrome, MAFLD/MASH, chronic kidney disease, and cardiometabolic risk across organ systems.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- MetsObesity: a novel classification system for predicting 15-year cardiovascular risk in the UK Biobank population. Save
- SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome. Save
- Response to Letter to the Editor From Hooper: "Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study". Save
- Safety and efficacy of sequential treatments for postmenopausal osteoporosis: a network meta-analysis of randomised controlled trials. Save
- Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: A systematic review and meta-analysis. Save
- Cardio-cerebrovascular Outcomes in MODY, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study. Save
- Fat distribution measurements by chemical shift-encoded transition region extraction predict the risk of hyperglycaemia, dyslipidaemia and metabolic syndrome in mice. Save
- Notch1 is a marker for in situ resting osteocytes in a 3-dimensional gel culture model. Save
- Plasticity of adipose tissues in response to fasting and refeeding declines with aging in mice. Save
- Exploring the role of lipoprotein(a) in cardiovascular diseases and diabetes in Chinese population. Save